Unclaimed brand
Cizzle Bio advances early cancer detection with minimally invasive biomarker-based blood test for lung cancers. Discover how the CIZ1B biomarker blood test support earlier answers for clinicians and patients.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#6E6E6E
Dove Gray
110, 110, 110
0, 0, 43
0, 0, 0, 57
#8DC9F7
Malibu
141, 201, 247
206, 87, 76
43, 19, 0, 3
#262262
Port Gore
38, 34, 98
244, 48, 26
61, 65, 0, 62
Cizzle Bio, Inc. is a pioneering biotechnology company focused on revolutionizing early lung cancer detection through innovative science and technology. With exclusive rights to the CIZ1B Biomarker detection in the USA and Canada, Cizzle Bio is dedicated to improving patient outcomes by developing groundbreaking diagnostic tools. The company's research and development efforts have resulted in proprietary monoclonal antibodies specific to lung cancer, aiming to facilitate earlier and more accurate diagnosis.
Under experienced leadership, including healthcare veterans like Bill Behnke and Dr. Ron Greeno, Cizzle Bio cultivates strategic partnerships across the healthcare ecosystem, collaborating with cancer centers and insurance companies to maximize the accessibility of its diagnostic solutions.
Cizzle Bio's commitment goes beyond diagnostics; they also engage in community outreach and educational initiatives to raise awareness about early detection and encourage participation in screening programs. With a vision for a future where lung cancer can be detected reliably and treated effectively, Cizzle Bio is truly transforming the landscape of lung cancer diagnostics.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
The Cizzle Bio name, logos and brand assets are trademarks of Cizzle Bio and its affiliates. Brandfetch isn't affiliated with or endorsed by Cizzle Bio. Their use is subject to Cizzle Bio's brand guidelines.
